Insulet
PODD
#2012
Rank
NZ$17.68 B
Marketcap
NZ$255.00
Share price
-3.69%
Change (1 day)
-56.72%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: NZ$17.68 Billion

As of November 2026 Insulet has a market cap of NZ$17.68 Billion. This makes Insulet the world's 2012th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$17.68 B-49.58%
2025NZ$35.08 B6.39%
2024NZ$32.97 B37.63%
2023NZ$23.95 B-25.6%
2022NZ$32.20 B19.86%
2021NZ$26.86 B15.02%
2020NZ$23.35 B46.58%
2019NZ$15.93 B127.67%
2018NZ$6.99 B23.81%
2017NZ$5.65 B80.97%
2016NZ$3.12 B-0.72%
2015NZ$3.14 B-4.93%
2014NZ$3.30 B33.6%
2013NZ$2.47 B98.59%
2012NZ$1.24 B9.09%
2011NZ$1.14 B25.25%
2010NZ$0.91 B22.99%
2009NZ$0.74 B117.68%
2008NZ$0.34 B-56.6%
2007NZ$0.78 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Insulet was reported to be:

NZ$17.68 Billion
by Nasdaq info icon info icon
NZ$17.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.195 T 6,660.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$329.64 B 1,763.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$234.69 B 1,226.75%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$2.243 T 12,583.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ$2.16 B-87.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$8.13 B-54.03%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$56.06 B 216.93%๐Ÿ‡บ๐Ÿ‡ธ USA